Translating basic cancer research into new cancer therapeutics

Trends in Molecular Medicine

Volumn 8, Issue , 2002, Pages S1-S9

  Workman, Paul ^a   Kaye, Stanley B ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CANCER RESEARCH; CANCER THERAPY; EDITORIAL; GENOME; HUMAN; TARGET ORGAN;

ANIMALS; HUMANS; NEOPLASMS; RESEARCH; THERAPEUTICS;

EID: 0036219647     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02319-5     Document Type: Editorial

References (15)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. Choosing anti-cancer drug targets in the postgenomic era
4. Millennium review. Discovering novel chemotherapeutic drugs for the third millennium
5. Mechanism-based target identification and drug discovery in cancer research
6. Scoring a bull's-eye against cancer genome targets
7. Changing times: Developing cancer drugs in genomeland
8. The hallmarks of cancer
9. Proliferation, cell cycle and apoptosis in cancer
10. Pharmacological rescue of mutant p53 conformation and function
11. Specific protection against breast cancers by cyclin D 1 ablation
12. The language of histone modifications
13. Histone acetylases and deacetylases in cell proliferation
14. Hsp90 as a new therapeutic agent for cancer therapy: The story unfolds